Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Shire plc Updates FY 2012 Revenue Guidance; Reaffirms FY 2012 EPS Guidance


Wednesday, 1 Aug 2012 07:01am EDT 

Shire plc announced that for fiscal 2012, it expects product sales growth to be in the low teens. Full year royalties and other revenues are now expected to be 25% to 35% lower year on year, a change from previous guidance as a result of lower royalties from Impax Laboratories Inc. Taken together, the Company expect that total revenues will still show double digit growth in fiscal 2012. The Company is on track to deliver double digit earnings growth in fiscal 2012. The Company reported revenue of $4.263 billion and EPS of $1.78 in fiscal 2011. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $4.71 billion and EPS of $1.97 for fiscal 2012. 

Company Quote

147.36
0.58 +0.40%
17 Apr 2014